Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.95 USD

4.95
4,360

0.00 (-0.08%)

Updated Aug 20, 2026 03:51 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.94%
2Buy18.22%
3Hold10.27%
4Sell5.79%
5Strong Sell3.20%
S&P50011.55%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 247)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

Earnings Preview: AllScripts Healthcare (MDRX) Q1 Earnings Expected to Decline

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Allscripts' FollowMyHealth Partners Ephraim McDowell Health

Allscripts' (MDRX) FollowMyHealth is an EHR-neutral patient engagement platform that allows patients to stay connected with their physicians.

Zacks Equity Research

Why Is AllScripts (MDRX) Down 17.1% Since Last Earnings Report?

AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Computer Systems & Jasper General Tie Up to Boost EHR Service

Computer Systems (CPSI) sees a series of developments in the EHR platform.

Zacks Equity Research

Allscripts Partners With Opargo to Boost Practice Management

Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.

Zacks Equity Research

Allscripts Strengthens Strategic Relationship with Pulse8

Pulse8 is likely to boost Allscripts' (MDRX) flagship platform Veradigm, and its existing health plan product suite that delivers pocket-friendly tools and services for health plan members.

Zacks Equity Research

Allscripts to Fortify Middle East Foothold With New Project

Qatar-based Alfardan Group and Chicago-based Northwestern Medicine select Allscripts (MDRX) for the launch of a project in the Middle East.

Zacks Equity Research

Allscripts (MDRX) Q4 Earnings Lag Estimates, Bookings Up Y/Y

Significant year-over-year rise in bookings favors Allscripts' (MDRX) fourth-quarter 2018 results.

Zacks Equity Research

AllScripts Healthcare (MDRX) Misses Q4 Earnings and Revenue Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of -4.76% and -4.53%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AllScripts Healthcare (MDRX) Earnings Expected to Grow: Should You Buy?

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.